Not applicableStudy completedNCT02671968
What this trial is testing
Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 1 Diabetes at High Risk for Low Glucose Values Using Multiple Daily Injections (MDI) in Germany (HYPODE-STUDY)
Who this might be right for
Diabetes
Science Consulting in Diabetes 141